We are live on ! Find out more
AGWCA

Annis Gardner Whiting Capital Advisors Portfolio holdings

AUM $666M
1-Year Est. Return 28.24%
This Fund
S&P 500
This Quarter Est. Return
+6.84%
1 Year Est. Return
+28.24%
3 Year Est. Return
+84.97%
5 Year Est. Return
10 Year Est. Return
AUM
$485M
AUM Growth
+$196M
Cap. Flow
+$174M
Cap. Flow %
35.9%
Top 10 Hldgs %
43%
Holding
1,449
New
117
Increased
348
Reduced
316
Closed
271

Top Sells

Rank Stock Value
1
IYW icon
iShares US Technology ETF
IYW
+$323K
2
TGNA
TEGNA Inc
TGNA
+$295K
3
GS icon
Goldman Sachs
GS
+$295K
4
MCK icon
McKesson
MCK
+$239K
5
ODC icon
Oil-Dri
ODC
+$231K

Sector Composition

Rank Sector Weight
1 Technology 15.3%
2 Financials 10.5%
3 Consumer Discretionary 7.93%
4 Communication Services 6.93%
5 Healthcare 4.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OUT icon
776
Outfront Media
OUT
$5.29B
$5.64K ﹤0.01%
308
-1
-0.3% -$18
CBT icon
777
Cabot Corp
CBT
$4.46B
$5.63K ﹤0.01%
74
NBIS
778
Nebius Group N.V.
NBIS
$46.7B
$5.61K ﹤0.01%
+50
New +$3.47K
VV icon
779
Vanguard Morningstar Large-Cap ETF
VV
$54.5B
$5.54K ﹤0.01%
18
VNT icon
780
Vontier
VNT
$4.63B
$5.54K ﹤0.01%
132
NXPI icon
781
NXP Semiconductors
NXPI
$58.9B
$5.24K ﹤0.01%
23
+3
+15% +$675
NPO icon
782
Enpro
NPO
$7.04B
$5.2K ﹤0.01%
23
SPMD icon
783
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.9B
$5.15K ﹤0.01%
90
ALB icon
784
Albemarle
ALB
$15.5B
$5.11K ﹤0.01%
63
+61
+3,050% +$4.71K
SNY icon
785
Sanofi
SNY
$104B
$5.1K ﹤0.01%
108
-904
-89% -$43.6K
NBIX icon
786
Neurocrine Biosciences
NBIX
$16.8B
$5.05K ﹤0.01%
36
PTGX icon
787
Protagonist Therapeutics
PTGX
$9.71B
$5.05K ﹤0.01%
76
MRX
788
Marex Group Limited Ordinary Shares
MRX
$4.36B
$5.01K ﹤0.01%
149
-51
-26% -$1.84K
CPRT icon
789
Copart
CPRT
$27.4B
$4.95K ﹤0.01%
110
-67
-38% -$3.16K
ENS icon
790
EnerSys
ENS
$6.79B
$4.86K ﹤0.01%
43
CROX icon
791
Crocs
CROX
$6.63B
$4.85K ﹤0.01%
58
-16
-22% -$1.46K
OLLI icon
792
Ollie's Bargain Outlet
OLLI
$4.8B
$4.75K ﹤0.01%
37
PARR icon
793
Par Pacific Holdings
PARR
$3.59B
$4.75K ﹤0.01%
134
EHC icon
794
Encompass Health
EHC
$12.5B
$4.7K ﹤0.01%
37
-85
-70% -$10.1K
VOX icon
795
Vanguard Communication Services ETF
VOX
$5.88B
$4.69K ﹤0.01%
25
WGO icon
796
Winnebago Industries
WGO
$906M
$4.68K ﹤0.01%
140
KTOS icon
797
Kratos Defense & Security Solutions
KTOS
$11.7B
$4.57K ﹤0.01%
50
SAP icon
798
SAP
SAP
$241B
$4.54K ﹤0.01%
17
-171
-91% -$48.1K
ODFL icon
799
Old Dominion Freight Line
ODFL
$44.1B
$4.5K ﹤0.01%
32
-25
-44% -$3.83K
IDA icon
800
Idacorp
IDA
$8.08B
$4.49K ﹤0.01%
34
-193
-85% -$23.9K

Similar funds

Annis Gardner Whiting Capital Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Annis Gardner Whiting Capital Advisors held 1,449 positions worth $485M, up 68% from $289M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Annis Gardner Whiting Capital Advisors deployed $174M of net new capital in Q3 2025, opening 117 new positions and adding to 348 existing holdings. Its largest new stake was iShares MSCI ACWI ETF: 83,076 shares worth $11.5M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares US Technology ETF, an estimated $323K trimmed.

  • Annis Gardner Whiting Capital Advisors's largest Q3 2025 buy was iShares MSCI ACWI ETF: 83,076 shares worth $11.5M.
  • Annis Gardner Whiting Capital Advisors added most to iShares MSCI EAFE ETF in Q3 2025, an estimated $71.6M increase.
  • Annis Gardner Whiting Capital Advisors's biggest Q3 2025 reduction was iShares US Technology ETF, cutting an estimated $323K.
  • Annis Gardner Whiting Capital Advisors fully exited iShares MSCI EAFE Value ETF in Q3 2025, selling an estimated $184K.
  • Annis Gardner Whiting Capital Advisors's ten largest holdings make up 43% of its $485M portfolio in Q3 2025.
  • Annis Gardner Whiting Capital Advisors opened 117 new positions and closed 271 in Q3 2025.
  • Annis Gardner Whiting Capital Advisors's portfolio value rose 68% quarter-over-quarter to $485M.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q3 2025, filed 3 Nov 2025.